REYL & Cie »

Esperion Therapeutics shares owned by REYL & Cie

Quarter-by-quarter ownership of Esperion Therapeutics (ESPR) shares owned by REYL & Cie from 13F filings

Historical chart of REYL & Cie investment in Esperion Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Esperion Therapeutics held by REYL & Cie consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Esperion Therapeutics by REYL & Cie

Quarter filed Position value Share count Share price at filing
2026-06-30 $23k 8.3k 2.75

More positions owned by REYL & Cie

Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Advanced Micro Devices (AMD)
Philip Morris International (PM)
NVIDIA Corporation (NVDA)
Coca-Cola Company (KO)
Applied Materials (AMAT)
Chevron Corporation (CVX)
JPMorgan Chase & Co. (JPM)
Ishares Tr Glob Hlthcre Etf (IXJ)
salesforce (CRM)
Vanguard Index Fds S&p 500 Etf Shs (VOO)

View all positions for REYL & Cie

Top funds holding Esperion Therapeutics

Glazer Capital
BlackRock
Vanguard Capital Management
Trium Capital
Goldman Sachs Group
Two Sigma Investments
State Street Corporation
Geode Capital Management
CNH Partners
Oddo Bhf Asset Management Sas
Balyasny Asset Management
FMR
Beryl Capital Management
PenderFund Capital Management
UBS Group

View all funds holding Esperion Therapeutics